SALUBRIS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SALUBRIS Trademark

Serial Number: 88133406 • Registration: 5952886

SALUBRIS is a trademark filed by SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. on September 26, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (10 trademarks)

37F, Main Tower, Lvjing Plaza,
Futian Dist. Shenzhen 518040 , CN

Entity Type: 99

Trademark Details

Filing Date

September 26, 2018

Registration Date

January 7, 2020

Published for Opposition

October 22, 2019

Goods & Services

Pharmaceutical preparations for use in treating diseases of the cardiovascular system and cerebrovascular system; Pharmaceutical preparations for use in treating cancerous tumors; Pharmaceutical preparations for use in treating metabolic diseases and diseases of the immune system and the musculo-skeletal system; Chemical preparations for pharmaceutical or medical purposes, namely, Pharmaceutical preparations for use in haematology, dermatology, ophthalmology and gastroenterology, Pharmaceutical preparations being anti-infectives, Pharmaceutical preparations for use in treating diseases of the respiratory system, the digestive system, and the endocrine system, Pharmaceutical preparations for use in treating hypersensitivity diseases; Medicines for human purpose for treating disease, namely, pharmaceutical preparations for use in treating diseases of the cardiovascular system and cerebrovascular system, pharmaceutical preparations for use in treating cancerous tumors, pharmaceutical preparations for use in treating metabolic diseases, as well as diseases of the immune system and the musculo-skeletal system; Active pharmaceutical ingredients in the nature of pharmaceutical preparations used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, and the musculo-skeletal system, and for treating cancerous tumors; Biochemical medicines for use in treating diseases of the cardiovascular system and cerebrovascular system; Biochemical medicines for use in treating cancerous tumors; Biochemical medicines for use in treating metabolic diseases, nervous system diseases as well as diseases of the immune system and the musculo-skeletal system; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the metabolic system, the respiratory system, and the musculo-skeletal system, pharmaceutical preparations for use in tissue and organ transplantation, for use in ophthalmology and for use in treatment of gastroenterological disorders

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 7, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 22, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 2, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 9, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 9, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 9, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 9, 2019 CNEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 7, 2019 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 6, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 6, 2019 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 6, 2019 CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 6, 2019 CHAN
ASSIGNED TO LIE
Aug 5, 2019 ALIE
NOTICE OF REVIVAL - E-MAILED
Jul 31, 2019 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 30, 2019 TROA
PETITION TO REVIVE-GRANTED
Jul 30, 2019 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 30, 2019 PROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 29, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 29, 2019 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2019 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 17, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 17, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 17, 2019 CNRT
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jan 16, 2019 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 16, 2019 PARI
ASSIGNED TO EXAMINER
Jan 8, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2018 NWOS
NEW APPLICATION ENTERED
Sep 29, 2018 NWAP